Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kimberly D Leuthner"'
Publikováno v:
Expert Review of Anti-infective Therapy. 13:149-159
In the era of increasing antibiotic resistance, development of new agents that could provide therapeutic options for difficult to treat pathogens is vital. Dalbavancin is a new lipoglycopeptide recently approved by the US FDA for the treatment of acu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da8ce31674adf22aea8146756ead33f7
https://doi.org/10.1586/14787210.2015.995633
https://doi.org/10.1586/14787210.2015.995633
Autor:
Gary V. Doern, Kimberly D. Leuthner
Publikováno v:
Journal of Clinical Microbiology. 51:3916-3920
The development of antimicrobial agents represents one of the most significant achievements in medicine during the past century. However, the emergence of antimicrobial resistance combined with the downturn in the development of new antimicrobial age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::991a9459429329d9c00f6b8b3cdfcaa1
https://doi.org/10.1128/jcm.01751-13
https://doi.org/10.1128/jcm.01751-13
Publikováno v:
Journal of Pharmacy Practice. 26:506-513
Antimicrobial stewardship programs are essential to health care institutions to promote the appropriate use of antibiotics not only to decrease antimicrobial resistance but to prevent the spread and infection of Clostridium difficile. Clostridium dif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6fc8a8213b4a5c0117412d5f2ba89a9
https://doi.org/10.1177/0897190013499528
https://doi.org/10.1177/0897190013499528
Publikováno v:
Open Forum Infectious Diseases. 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6742f48b213fb6e9502e2b5b3508061f
https://doi.org/10.1093/ofid/ofw172.1357
https://doi.org/10.1093/ofid/ofw172.1357
Autor:
Laura A Puzniak, Ravina Kullar, Kimberly D Leuthner, David A Hewlett, Becky Jayakumar, Truong Nguyen
Publikováno v:
Open Forum Infectious Diseases
Background There is a global increase in Gram-negative (GN) pathogens, with Enterobacteriaceae and Pseudomonas aeruginosa(PSA) being the major threats in clinical practice. C/T is a novel antipseudomonal cephalosporin combined with an established β-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1e5802b1d174c9e5d27e591e722fb29
http://europepmc.org/articles/PMC5632114
http://europepmc.org/articles/PMC5632114
Autor:
Thomas P. Lodise, Marcus J. Zervos, Katherine Reyes, James A. McKinnell, Karri A. Bauer, Romic Eskandarian, Kimberly D Leuthner, Darren L. Culshaw, Joyce Bensman, Annie Wong-Beringer, Saira B. Chaudhry, Winter J. Smith, Kenneth C. Lamp, Robert Adamson, Pamela A. Moise, Michael Virata, Debra A. Goff
Publikováno v:
Clinical therapeutics. 38(1)
Purpose Clinical studies comparing vancomycin with alternative therapy for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia are limited. The objective of this study was to compare outcomes of early daptomycin versus vancomycin treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7b26c20804833a3b6b510e09727c882
https://pubmed.ncbi.nlm.nih.gov/26585355
https://pubmed.ncbi.nlm.nih.gov/26585355
Publikováno v:
Antimicrobial Agents and Chemotherapy. 50:1298-1303
We inoculated an in vitro pharmacodynamic model simultaneously with clinical isolates of methicillin-resistant Staphylococcus aureus and an enterocin-producing enterococcus (vancomycin-resistant Enterococcus faecalis , ampicillin susceptible) at 7 lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40c4a1499a7fc66d5d3167f40d1c6db3
https://doi.org/10.1128/aac.50.4.1298-1303.2006
https://doi.org/10.1128/aac.50.4.1298-1303.2006
Publikováno v:
Antimicrobial Agents and Chemotherapy. 50:813-816
We evaluated pulsatile dosing of clarithromycin and amoxicillin alone or combined against Streptococcus pneumoniae with various susceptibilities. When combined, pulsatile amoxicillin with clarithromycin was superior to either 8- or 12-h dosing agains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c1aa6da2b9251294113c6c742b75618
https://doi.org/10.1128/aac.50.2.813-816.2006
https://doi.org/10.1128/aac.50.2.813-816.2006
Publikováno v:
Open Forum Infectious Diseases
Background Mucormycosis (MC) is a group of invasive fungal infections with a mortality rate approaching 100% in disseminated disease. The incidence of MC is low, with one study estimating 500 cases/year in the United States, making optimal treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec9e0089910b700d22c06bc6ca7781ec
https://doi.org/10.1093/ofid/ofx163.042
https://doi.org/10.1093/ofid/ofx163.042
Publikováno v:
Therapeutics and Clinical Risk Management
Acute bacterial skin and skin structure infections (ABSSSI) are a common disease causing patients to seek treatment through the health care system. With the continued increase of drug-resistant bacterial pathogens, these infections are becoming more
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddf392581e425359202b7574b71f1326
https://doi.org/10.2147/tcrm.s86330
https://doi.org/10.2147/tcrm.s86330